Latest News about BIIB
Recent news which mentions BIIB
Why the FDA didn’t grant an approval to Lilly’s Alzheimer’s drug
January 20, 2023
From MarketWatch
Tech Stocks Get Netflix Boost Amid Jittery Wider Market On Friday, Dow Stares At 4th Straight Loss
January 20, 2023
From Benzinga
From Benzinga
$100 Invested In Biogen 20 Years Ago Would Be Worth This Much Today
January 19, 2023
Tickers
BIIB
From Benzinga
From Motley Fool
Tickers
BIIB
From Motley Fool
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
January 18, 2023
From Benzinga
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
January 17, 2023
From Motley Fool
1 Hot Growth Stock to Buy Now, and 1 to Avoid
January 11, 2023
From Motley Fool
From Motley Fool
Barron's Top Weekend Stock Picks: Tesla, Snowflake, Delta And Why Warren Buffett's Berkshire Hathaway May Be In For Big Tax Bill
January 07, 2023
From Benzinga
From Benzinga
From Benzinga
FDA approves treatment for people with mild forms of Alzheimer’s
January 06, 2023
From MarketWatch
From Benzinga
Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?
January 06, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2023
From Benzinga
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
From Motley Fool
Could Eli Lilly Stock Help You Become a Millionaire?
January 05, 2023
From Motley Fool
Amid criticism for its handling of another Alzheimer’s drug, FDA will decide this week whether to approve lecanemab
January 03, 2023
From MarketWatch
1 Large-Cap Biotech Stock to Buy for 2023 and Beyond
January 03, 2023
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
From Benzinga
3 Nasdaq Stocks That Are Up 25% in 3 Months
December 23, 2022
From Motley Fool
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
From Motley Fool
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
December 22, 2022
From Benzinga
Has This Top Pharma Company Found Its Next Billion-Dollar Product?
December 22, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.